Target Identification/ Validation News for January 2013

Launch of trial of ‘master switch’ drug to treat several cancer types Launch of trial of ‘master switch’ drug to treat several cancer types

Cancer Research UK and its commercial arm Cancer Research Technology (CRT) are launching a trial of an experimental drug shown to simultaneously block many enzymes that control cancer cell growth and death. The ‘master-switch’ experimental drug, owned by Astex Pharmaceuticals, could potentially treat a range of cancer types.
21 January, 2013